A Multicenter, RAndomlzed, coNtrolled, umBrella Trial fOr Minimally Invasive Neurosurgery With Al-assisted Robotic guidanCe for Hemorrhagic Stroke

NANot yet recruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Basal Ganglia HemorrhageIntraventricular HemorrhageBrainstem StrokeIntracranial Hemorrhage, Spontaneous
Interventions
PROCEDURE

AI-assisted robotic-guided endoscopic hematoma evacuation

Surgical removal of hematoma using AI-assisted robotic-guided stereotactic navigation and endoscopic aspiration techniques.

PROCEDURE

Conventional craniotomy

Standard open surgical evacuation of hematoma through craniotomy.

PROCEDURE

AI-assisted robotic-guided puncture and hematoma evacuation

AI-assisted robotic-guided stereotactic puncture and aspiration of hematoma.

OTHER

Standard medical management

Guideline-based conservative therapy without surgical hematoma evacuation.

PROCEDURE

AI-assisted robotic-guided endoscopic ventricular hematoma evacuation plus external ventricular drainage

AI-assisted robotic-guided endoscopic evacuation of ventricular hematoma combined with external ventricular drainage.

PROCEDURE

External ventricular drainage (EVD)

Conventional ventricular catheter placement for hematoma drainage.

Trial Locations (1)

310000

The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
collaborator

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

OTHER

collaborator

Huashan Hospital

OTHER

collaborator

China-Japan Friendship Hospital

OTHER

lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

NCT07205263 - A Multicenter, RAndomlzed, coNtrolled, umBrella Trial fOr Minimally Invasive Neurosurgery With Al-assisted Robotic guidanCe for Hemorrhagic Stroke | Biotech Hunter | Biotech Hunter